Liver transplantation for hepatitis B: The con aspect

Liver Transplantation and SurgeryVolume 1, Issue 4 p. 265-270 The CruicibleFree Access Liver transplantation for hepatitis B: The con aspect Russell H. Wiesner MD, Corresponding Author Russell H. Wiesner MD Divisions of Hepatology, Mayo Clinic and Mayo Foundation, Rochester, MNMedical Director of Liver Transplantation, 200 First Street, SW, Rochester, MN 55905Search for more papers by this authorRuud A. F. Krom, Ruud A. F. Krom Transplantation Surgery, Mayo Clinic and Mayo Foundation, Rochester, MNSearch for more papers by this author Russell H. Wiesner MD, Corresponding Author Russell H. Wiesner MD Divisions of Hepatology, Mayo Clinic and Mayo Foundation, Rochester, MNMedical Director of Liver Transplantation, 200 First Street, SW, Rochester, MN 55905Search for more papers by this authorRuud A. F. Krom, Ruud A. F. Krom Transplantation Surgery, Mayo Clinic and Mayo Foundation, Rochester, MNSearch for more papers by this author First published: July 1995 https://doi.org/10.1002/lt.500010415Citations: 13AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References 1 Adams PC, Ghent CN, Grant DR, Wall WJ. Employment after liver transplantation. Hepatology 1995; 21: 140– 144. 2 Lowe D, O'Grady JG, McEwen J, Williams R. Quality of life following liver transplantation. A preliminary report. J R Coll Physicians Lond 1990; 24: 43– 46. 3 O'Grady JG, Smith HM, Davies SE, Daniels HM, Donaldson PT, Tan KC, et al. Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. J Hepatol 1992; 14: 104– 111. 4 Lucey MR, Graham DM, Martin P, DiBisceglie A, Rosenthal S, Waggoner JC, et al. Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation. Gut 1992; 33: 1390– 1396. 5 Mora NP, Klintmalm GB, Poplawski SS, Cofer JB, Husberg BS, Gonwa TA, et al. Recurrence of hepatitis B after liver transplantation: Does hepatitis B immunoglobulin modify the recurrent disease. Transplant Proc 1990; 22: 1549– 1550. 6 Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329: 1842– 1847. 7 Van Thiel DH, Wright HI, Fagiuoli S. Liver transplantation for hepatitis B virus-associated cirrhosis: A progress report. Hepatology 1994; 20 (Suppl): 20S– 23S. 8 Benner KG, Lee RG, Keeffe EB, Lopez RR, Sasaki AW, Pinson CW, et al. Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. Gastroenterology 1992; 103: 1307– 1312. 9 Lau JY, Bain VG, Davies SE, O'Grady JG, Alberti A, Alexander GJ, et al. High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. Gastroenterology 1992; 102: 956– 962. 10 Davies SE, Portmann BC, O'Grady JG, Aldis PM, Chaggar K, Alexander GJ, et al. Hepatic histologic findings after transplantation for chronic hepatitis B virus infection; including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991; 13: 150– 157. 11 Marcellin P, Samuel D, Areias J, Loriot MA, Arulnaden JL, Gigou M, et al. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease. Hepatology 1994; 19: 6– 12. 12 Hopf U, Neuhaus P, Lobeck H, Konig V, Kuther S, Bauditz J, et al. Follow-up of recurrent hepatitis and delta infection in liver allograft recipients after treatment with recombinant interferon α. J Hepatol 1993; 13: 339– 346. 13 CDC. Protection against viral hepatitis: Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1990; 39: 5– 22. 14 Belle SH, Beringer KC, Murphy JB, Detre KM. The Pitt-UNOS Liver transplant registry. In: Terasaki-Cecka (eds). Clinical Transplants. Los Angeles: UCLA Tissue Typing 1993: 19– 36. 15 Brechot C, Bernuau J, Thiers V, Dubois F, Goudeau A, Rueff B, et al. Multiplication of hepatitis B virus in fulminant hepatitis B. BMJ 1984; 288: 270– 271. 16 Krogsgaard K, Kryger P, Alderschvile J, Andersson P, Sorensen TI, Nielsen JO, et al. Delta infection and suppression of hepatitis B virus replication in chronic HBsAg Carriers. Hepatology 1987; 7: 42– 45. 17 Rizzetto M, Recchia S, Salizzoni M. Liver transplantation in carriers of the HBsAg. J Hepatol 1991; 13: 5– 7. 18 Samuel D, Bismuth A, Mathieu D, Arulnaden JL, Reynes M, Benhamou JP, et al. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet 1991; 337: 813– 815. 19 Samuel N, Ziznego A-L, Reynes M, Feray C, Arulnaden JL, David M-F, et al. Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis. Hepatology 1995; 21: 333– 339. 20 Eason JD, Freeman RB, Rohrer RJ, Lewis D, Jenkins R, Dienstag J, et al. Should liver transplantation be performed for patients with hepatitis B? Transplantation 1994; 57: 1588– 1593. 21 Goldstein L, Millis JM, Calquihoun SD, Gitnick G, Tong MJ, Busuttil RW. Liver transplantation for chronic hepatitis B in Asians. Transplantation 1994; 57: 1393– 1411. 22 Crippin J, Foster B, Carlen S, Borcich A, Bodenheimer H, Jr. Retransplantation in hepatitis B: A multicenter experience. Transplantation 1994; 57: 823– 826. Citing Literature Volume1, Issue4July 1995Pages 265-270 ReferencesRelatedInformation